Single-blind Lead-in, to Evaluate Safety and Biomarkers of
Resmetirom (MGL-3196) in Patients with Non-alcoholic Fatty Liver
Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension
(MAESTRO-NAFLD-OLE)
Please contact us for more information or to learn if you are eligible to participate.
